ResearcherConsorci Institut D'Investigacions Biomediques August Pi I SunyerActive in the last 2 years
Silvia Pascual-Sabater
Matched on ORCID iD 0000-0002-1074-0681; OpenAlex author ID A5022007265. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 8
2022: 1 paper · 2023: 1 paper · 2024: 2 papers · 2025: none · 2026: 1 paper
Papers 5
- DYRK1A coordinates tumor–stroma secretory programs that promote an immunosuppressive microenvironment in pancreatic cancer Co-author DOI 10.1038/s41420-026-03444-w↗
- The LAMB3-EGFR signaling pathway mediates synergistic Anti-Cancer effects of berberine and emodin in Pancreatic cancer. First author DOI 10.1016/j.bcp.2024.116509↗
- Aronia Berry Extract Modulates MYD88/NF-kB/P-Glycoprotein Axis to Overcome Gemcitabine Resistance in Pancreatic Cancer. Co-author DOI 10.3390/ph17070911↗
- Andrographis Reverses Gemcitabine Resistance through Regulation of ERBB3 and Calcium Signaling Pathway in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/biomedicines11010119↗
- Berberine Overcomes Gemcitabine-Associated Chemoresistance through Regulation of Rap1/PI3K-Akt Signaling in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/ph15101199↗
Closest collaborators
The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Cristina Fillat Fonts · 5 shared papers, 2022–2026 · strength 1.25
- Paper DYRK1A coordinates tumor–stroma secretory programs that promote an immunosuppressive microenvironment in pancreatic can… DOI 10.1038/s41420-026-03444-w↗
- Paper The LAMB3-EGFR signaling pathway mediates synergistic Anti-Cancer effects of berberine and emodin in Pancreatic cancer. DOI 10.1016/j.bcp.2024.116509↗
- Paper Aronia Berry Extract Modulates MYD88/NF-kB/P-Glycoprotein Axis to Overcome Gemcitabine Resistance in Pancreatic Cancer. DOI 10.3390/ph17070911↗
- Caiming Xu · 4 shared papers, 2022–2024 · strength 0.92
- Paper The LAMB3-EGFR signaling pathway mediates synergistic Anti-Cancer effects of berberine and emodin in Pancreatic cancer. DOI 10.1016/j.bcp.2024.116509↗
- Paper Aronia Berry Extract Modulates MYD88/NF-kB/P-Glycoprotein Axis to Overcome Gemcitabine Resistance in Pancreatic Cancer. DOI 10.3390/ph17070911↗
- Paper Andrographis Reverses Gemcitabine Resistance through Regulation of ERBB3 and Calcium Signaling Pathway in Pancreatic Du… DOI 10.3390/biomedicines11010119↗
- Ajay Goel · 4 shared papers, 2022–2024 · strength 0.92
- Paper The LAMB3-EGFR signaling pathway mediates synergistic Anti-Cancer effects of berberine and emodin in Pancreatic cancer. DOI 10.1016/j.bcp.2024.116509↗
- Paper Aronia Berry Extract Modulates MYD88/NF-kB/P-Glycoprotein Axis to Overcome Gemcitabine Resistance in Pancreatic Cancer. DOI 10.3390/ph17070911↗
- Paper Andrographis Reverses Gemcitabine Resistance through Regulation of ERBB3 and Calcium Signaling Pathway in Pancreatic Du… DOI 10.3390/biomedicines11010119↗
- Haiyong Han · 3 shared papers, 2022–2024 · strength 0.61
- Paper Aronia Berry Extract Modulates MYD88/NF-kB/P-Glycoprotein Axis to Overcome Gemcitabine Resistance in Pancreatic Cancer. DOI 10.3390/ph17070911↗
- Paper Andrographis Reverses Gemcitabine Resistance through Regulation of ERBB3 and Calcium Signaling Pathway in Pancreatic Du… DOI 10.3390/biomedicines11010119↗
- Paper Berberine Overcomes Gemcitabine-Associated Chemoresistance through Regulation of Rap1/PI3K-Akt Signaling in Pancreatic … DOI 10.3390/ph15101199↗
- Keisuke Okuno · 2 shared papers, 2022–2023 · strength 0.35
- Paper Andrographis Reverses Gemcitabine Resistance through Regulation of ERBB3 and Calcium Signaling Pathway in Pancreatic Du… DOI 10.3390/biomedicines11010119↗
- Paper Berberine Overcomes Gemcitabine-Associated Chemoresistance through Regulation of Rap1/PI3K-Akt Signaling in Pancreatic … DOI 10.3390/ph15101199↗
- Susana de la Luna · 1 shared paper, 2026 · strength 0.33
- Yuan Li · 1 shared paper, 2024 · strength 0.26
- Tetsuji Takayama · 1 shared paper, 2023 · strength 0.18
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.